Company profile

Sensorion

Our mission: find solutions for hearing disorders

Industry
Biotechnology Research
Employees
83
Headquarters
Montpellier, Occitanie
Founded
2009
LinkedIn followers
9,526
Office locations
1

Sensorion company summary

Sensorion is a company in the Biotechnology Research industry, headquartered in Montpellier, Occitanie, founded in 2009. On LinkedIn the company has around 83 employees and 9,526 followers. Its listed specialties include gene therapy, small molecule, inner ear, biotech.

What technology does Sensorion use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Sensorion

Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs aimed at correcting hereditary monogenic forms of deafness including OTOF-GT, targeting deafness caused by a mutation of the gene encoding for otoferlin, and hearing loss related to mutation in GJB2 gene to potentially address important hearing loss segments in adults and children (GJB2-GT).

Specialties

gene therapysmall moleculeinner earbiotech

Where is Sensorion located?

Sensorion lists 1 location.

Montpellier, Occitanie, FRHQ
375, rue du Professeur Joseph Blayac

Compare companies similar to Sensorion

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Sensorion
sensorion.com
Biotechnology Research832009Montpellier, Occitanie
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Sensorion

What does Sensorion do?

Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs aimed at correcting hereditary monogenic forms of deafness including OTOF-GT, targeting deafness caused by a mutation of the gene encoding for otoferlin, and hearing loss related to mutation in GJB2 gene to potentially address important hearing loss segments in adults and children (GJB2-GT).

How many employees does Sensorion have?

Sensorion has around 83 employees on LinkedIn.

Where is Sensorion headquartered?

Sensorion is headquartered in Montpellier, Occitanie.

When was Sensorion founded?

Sensorion was founded in 2009.

Build a lead list from companies like Sensorion

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.